Drugs / Technetium-99m Sulfur Colloid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT03049345 | Jul 2016 → Jun 2022 | gastric cancer | McGill University Health Centre/Research Institute of the McGill University Health Centre | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01660412 Comparator | Aug 2012 → Dec 2016 | — | University of Arkansas | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Technetium-99m Sulfur Colloid | “Does Alkalinization of Technetium-99m Sulfur Colloid Reduce Perceived Pain Levels During Non-breast Sentinel Lymphoscintigraphy?” NCT01660412 ↗1“2mL of endoscopically-placed technetium 99m sulfur colloid solution will be injected submucosally at 4 points around the tumour.” NCT03049345 ↗ |
| Route | Other | “technetium 99m sulfur colloid solution will be injected submucosally” NCT03049345 ↗ |